Michigan Supreme Court Clears Path for Lilly Insulin Pricing Probe

References

1. 1.Silverman, E. (2026, August 2). Michigan Supreme Court ruling allows probe into Lilly insulin pricing. STAT News. https://www.statnews.com/pharmalot/2026/08/02/michigan-supreme-court-ruling-allows-probe-into-lilly-insulin-pricing/
2. 2.Herkert, D., Vijayakumar, P., Luo, J., Schwartz, J. I., Rabin, T. L., DeFilippo, E., & Lipska, K. J. (2019). Cost-related insulin underuse among patients with diabetes. JAMA Internal Medicine, 179(1), 112–114. https://doi.org/10.1001/jamainternmed.2018.5008
3. 3.Lipska, K. J., & Hirsch, I. B. (2019). Rationing insulin: the cost of a century-old drug. New England Journal of Medicine, 381(4), 393–395. https://doi.org/10.1056/NEJMp1905623
4. 4.Rajkumar, S. V. (2020). The high cost of insulin in the United States: an urgent call to action. Mayo Clinic Proceedings, 95(1), 22–28. https://doi.org/10.1016/j.mayocp.2020.01.001
5. 5.Vallis, M., Berard, L., Cooke, A., Ekoe, J. M., & Goldenberg, R. (2020). Screening for medication non-adherence in diabetes: clinical considerations. Canadian Journal of Diabetes, 44(2), 111–118. https://doi.org/10.1016/j.jcjd.2019.07.003
6. 6.Australian Institute of Health and Welfare. (2023). Diabetes: Australian facts 2023. AIHW. https://www.aihw.gov.au/reports/diabetes/diabetes/contents/summary
7. 7.Cubanski, J., Damico, A., & Neuman, T. (2023). How the Inflation Reduction Act insulin provisions affect Medicare beneficiaries. KFF Health News. https://www.kff.org/medicare/issue-brief/how-the-inflation-reduction-act-insulin-provisions-affect-medicare-beneficiaries/
8. 8.Cefalu, W. T., Dawes, D. E., Gavlak, G., Goldman, D., Herman, W. H., Van Nuys, K., Powers, A. C., Taylor, S. I., & Yatvin, A. L. (2018). Insulin access and affordability working group: conclusions and recommendations. Diabetes Care, 41(6), 1299–1311. https://doi.org/10.2337/dci18-0019